Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-07-01 16:37:26 ET · period of report 2026-06-30 · accession 0002043395-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:37 | 2026-06-30 | FENC | Sayad Pierre Sargis | Chief Medical Off | A - Grant | $0.00 | +168 | 21.2K | +0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-06-30 | A | A | 168 | $0.00 | 21,183 | D | — | — | (F1) Represents shares released from restriction from shares awarded 3/28/2025. |